Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era

Published:2012-06 Issue:3 Volume:76 Page:387-392
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Park Jin Hyun,Kim Yu Jung,Lee Jeong-Ok,Lee Keun-Wook,Kim Jee Hyun,Bang Soo-Mee,Chung Jin-Haeng,Kim Jae Sung,Lee Jong Seok

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Leptomeningeal metastasis;Chamberlain;Semin Neurol,2010

2. Pronostic factors of synchronous brain metastases from lung cancer;Penel;Lung Cancer,2001

3. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials;Gaspar;Int J Radiat Oncol Biol Phys,1997

4. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI;Yi;Lung Cancer,2009

5. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients;Wasserstrom;Cancer,1982

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Treatment Advances in Lung Cancer with Leptomeningeal Metastasis;Current Cancer Drug Targets;2024-09

3. Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis;Cell Biology International;2024-08-13

4. Radiotherapy and Systemic Treatment for Leptomeningeal Disease;Biomedicines;2024-08-07

5. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3